Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report)’s stock price shot up 2.5% during mid-day trading on Thursday . The company traded as high as $0.5999 and last traded at $0.5730. 677,364 shares were traded during trading, an increase of 2,894% from the average session volume of 22,626 shares. The stock had previously closed at $0.5591.
Bellevue Life Sciences Acquisition Stock Up 2.5%
The stock has a 50 day simple moving average of $0.67 and a two-hundred day simple moving average of $0.67.
About Bellevue Life Sciences Acquisition
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.
BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.
Featured Articles
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
